about
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetu...
Read More
199.57
1.09
(0.55%)
2.7M
XNAS Volume
High volume today
XNAS 07 Nov, 2025 4:30 PM (EST)
Insider Trade
Matthew Rabinowitz, Executive Chairman of Natera, sells 22.9K shares worth $4.6 million
See details
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Natera Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..